Effect of membrane composition and structure on solute removal and biocompatibility in hemodialysis.

Effect of membrane composition and structure on solute removal and biocompatibility in hemodialysis. Significant changes in extracorporeal membranes have occurred over the past five decades in which hemodialysis (HD) has been available as a therapy for both acute renal failure (ARF) and end-stage renal disease (ESRD). For cellulosic membranes, these changes have included a reduction in thickness, hydroxyl group substitution, and an increase in pore size. These modifications have resulted in enhanced efficiency of small solute removal, a broader spectrum of overall solute removal, and an attenuation of complement activation in comparison to the thick, unsubstituted cellulosic membranes of low permeability used in the early days of HD therapy. Synthetic membranes, originally developed specifically for use in high-flux HD and hemofiltration, have also evolved during this same time period. In fact, the initially clear distinction between low-flux regenerated cellulosic and high-flux synthetic membranes has become blurred, as membrane formulators have developed products designed to appeal to enthusiasts for both membrane formats. The purpose of this review is to characterize both the solute removal and biocompatibility characteristics of dialysis membranes according to their composition (that is, polymeric makeup) and structure. In this regard, the manner in which membrane biocompatibility interacts with flux is highlighted.

[1]  M. Daha,et al.  Biocompatibility and Performance of a Modified Cellulosic and a Synthetic High Flux Dialyzer: A Randomized Crossover Comparison Between Cellulose Triacetate and Polysulphon , 1995, ASAIO journal.

[2]  K. Nolph,et al.  Ultrafiltration: a mechanism for removal of intermediate molecular weight substances in coil dialyzers. , 1974, Kidney international.

[3]  C Ronco,et al.  Impact of Spacing Filaments External to Hollow Fibers on Dialysate flow Distribution and Dialyzer Performance , 1997, The International journal of artificial organs.

[4]  M. Kazatchkine,et al.  Induction of IL-1 during hemodialysis: transmembrane passage of intact endotoxins (LPS). , 1990, Kidney international.

[5]  D. Lane,et al.  The scientific basis for selection of measures of thrombogenicity. , 1994, Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association.

[6]  A. Dalmasso,et al.  Hemodialysis leukopenia. Pulmonary vascular leukostasis resulting from complement activation by dialyzer cellophane membranes. , 1977, The Journal of clinical investigation.

[7]  C. Ronco,et al.  Beta 2-microglobulin Removal by Synthetic Dialysis Membranes. Mechanisms and Kinetics of the Molecule , 1997, The International journal of artificial organs.

[8]  E. Klein,et al.  Endotoxin and Bacterial Contamination of Dialysis Center Water and Dialysate; a Cross Sectional Survey , 1990, The International journal of artificial organs.

[9]  K. Jindal,et al.  A study of the basic principles determining the performance of several high-flux dialyzers. , 1989, American journal of kidney diseases : the official journal of the National Kidney Foundation.

[10]  G. Lonnemann.  Dialysate bacteriological quality and the permeability of dialyzer membranes to pyrogens. , 1993, Kidney international. Supplement.

[11]  E. Lee,et al.  Pharmacokinetics of Intravenous Vancomycin in Patients with End‐Stage Renal Failure , 1990, Therapeutic drug monitoring.

[12]  M. Seitz,et al.  Biocompatibility Differences with Respect to the Dialyzer Sterilization Method , 1998, Nephron.

[13]  K. Schaefer,et al.  Different handling of beta 2-microglobulin during hemodialysis and hemofiltration. , 1988, Nephron.

[14]  E. Ritz,et al.  Bioincompatibility of dialysis membranes: factor H binding correlates inversely with complement activation indicating a local imbalance of involved proteases/anti-proteases. , 1988, Advances in experimental medicine and biology.

[15]  N. Hoenich,et al.  Clinical comparison of high-flux cellulose acetate and synthetic membranes. , 1994, Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association.

[16]  C. Ronco,et al.  Haemodialysers and Associated Devices , 1996 .

[17]  M. Goldman,et al.  Adsorption of ß2-Microglobulin on Dialysis Membranes: Comparison of Different Dialyzers and Effects of Reuse Procedures , 1989, The International journal of artificial organs.

[18]  W. Hörl,et al.  Immune dysfunction in uremia. , 1997, Kidney international. Supplement.

[19]  M. Lysaght.  Hemodialysis membranes in transition. , 1988, Contributions to nephrology.

[20]  H. Strathmann,et al.  Basic features of the polyamide membranes. , 1992, Contributions to nephrology.

[21]  J. Floege,et al.  β2-Microglobulin Kinetics During Haemofiltration , 1988 .

[22]  C. Dinarello,et al.  Transcription, not synthesis, of interleukin-1 and tumor necrosis factor by complement. , 1990, Kidney international.

[23]  A. Cheung,et al.  Effects of Hemodialyzer Reuse on Clearances of Urea and β2-Microglobulin , 1999 .

[24]  J. Rotschafer,et al.  Vancomycin pharmacokinetics in patients with various degrees of renal function , 1988, Antimicrobial Agents and Chemotherapy.

[25]  L. Henderson,et al.  Biophysics of Ultrafiltration and Hemofiltration , 1996 .

[26]  B. Branger,et al.  β2-Microglobulin Kinetics During Haemodialysis and Haemofiltration , 1987 .

[27]  B. Pereira.  Cytokine production in patients on dialysis. , 1995, Blood purification.

[28]  L. Smeby,et al.  Microdomain structure of polymeric surfaces--potential for improving blood treatment procedures. , 1998, Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association.

[29]  B. Jaber,et al.  Effect of formaldehyde/bleach reprocessing on in vivo performances of high-efficiency cellulose and high-flux polysulfone dialyzers. , 1998, Journal of the American Society of Nephrology : JASN.

[30]  A. Cheung,et al.  Activation of complement by hemodialysis membranes: polyacrylonitrile binds more C3a than cuprophan. , 1990, Kidney international.

[31]  J. Hertel,et al.  Permeability and secondary membrane formation of a high flux polysulfone hemofilter. , 1986, Kidney international.

[32]  J T Daugirdas,et al.  Hemodialyzer mass transfer-area coefficients for urea increase at high dialysate flow rates. The Hemodialysis (HEMO) Study. , 1997, Kidney international.

[33]  R. Ward,et al.  A comparison of dialysers with low-flux membranes: significant differences in spite of many similarities. , 1997, Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association.

[34]  M J Lysaght,et al.  Kinetics of hemodiafiltration. I. In vitro transport characteristics of a hollow-fiber blood ultrafilter. , 1975, The Journal of laboratory and clinical medicine.

[35]  W. Hörl,et al.  Ofloxacin clearance during hemodialysis: a comparison of polysulfone and cellulose acetate hemodialyzers. , 1998, American journal of kidney diseases : the official journal of the National Kidney Foundation.

[36]  B. Descamps-Latscha,et al.  Permeability of cellulosic and non-cellulosic membranes to endotoxin subunits and cytokine production during in-vitro haemodialysis. , 1992, Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association.

[37]  G. Lonnemann,et al.  The role of plasma coating on the permeation of cytokine-inducing substances through dialyser membranes. , 1995, Nephrology, Dialysis and Transplantation.

[38]  D Luehmann,et al.  Technical requirements for rapid high-efficiency therapies. , 1986, Artificial organs.

[39]  N A Hoenich,et al.  Clinical characterization of Dicea a new cellulose membrane for haemodialysis. , 1997, Clinical nephrology.

[40]  L. Henderson,et al.  Kinetics of hemodiafiltration. II. Clinical characterization of a new blood cleansing modality. , 1975, The Journal of laboratory and clinical medicine.

[41]  D. Walb,et al.  Transmembranous Transport and Adsorption of Beta-2-microglobulin during Hemodialysis using Polysulfone, polyacrylonitrile, polymethylmethacrylate and Cuprammonium Rayon Membranes , 1989, The International journal of artificial organs.

[42]  D. Churchill,et al.  Effects of two low-flux cellulose acetate dialysers on plasma lipids and lipoproteins--a cross-over trial. , 1998, Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association.

[43]  S. Barnum,et al.  Renal filtration and catabolism of complement protein D. , 1985, The New England journal of medicine.

[44]  W. Hörl,et al.  Isolation of a granulocyte inhibitory protein from uraemic patients with homology of beta 2-microglobulin. , 1994, Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association.

[45]  L. Chiarantini,et al.  Bioreactivity and biocompatibility of a vitamin E-modified multi-layer hemodialysis filter. , 1998, Kidney international.

[46]  D. Fearon,et al.  Biocompatibility of dialysis membranes: effects of chronic complement activation. , 1984, Kidney international.

[47]  I Ledebo,et al.  Principles and practice of hemofiltration and hemodiafiltration. , 1998, Artificial organs.

[48]  W R Clark,et al.  Membrane adsorption of beta 2-microglobulin: equilibrium and kinetic characterization. , 1994, Kidney International.

[49]  B. Branger,et al.  High-flux synthetic versus cellulosic membranes for beta 2-microglobulin removal during hemodialysis, hemodiafiltration and hemofiltration. , 1989, Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association.

[50]  J. Volanakis,et al.  Metabolism of complement factor D in renal failure. , 1988, Kidney international.

[51]  B. Descamps-Latscha,et al.  Influence of Haemodialysis Membranes on β2-Microlobulin Kinetics:In Vivo and In Vitro Studies , 1988 .

[52]  M. Lysaght.  Evolution of hemodialysis membranes. , 1995, Contributions to nephrology.

[53]  W. Clark,et al.  Vancomycin mass transfer characteristics of high-flux cellulosic dialysers. , 1997, Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association.

[54]  K. Sakai,et al.  Removal of beta-2-microglobulin by diffusion alone is feasible using highly permeable dialysis membranes. , 1988, ASAIO transactions.

[55]  E. Ritz,et al.  Fluid phase generation of terminal complement complex as a novel index of bioincompatibility. , 1990, Kidney international.

[56]  J. Floege,et al.  Detection of endotoxin-like interleukin-1-inducing activity during in vitro dialysis. , 1988, Kidney international.

[57]  P. Södersten,et al.  Middle-sized molecule fractions isolated from uremic ultrafiltrate and normal urine inhibit ingestive behavior in the rat. , 1996, Journal of the American Society of Nephrology : JASN.

[58]  S. Goldfarb,et al.  Proinflammatory cytokines and hemofiltration membranes. , 1994, Journal of the American Society of Nephrology : JASN.

[59]  B. Molitoris,et al.  Plasma protein adsorption to highly permeable hemodialysis membranes. , 1995, Kidney international.

[60]  M. Daha,et al.  Cytokine profiles during clinical high-flux dialysis: no evidence for cytokine generation by circulating monocytes. , 1997, Journal of the American Society of Nephrology : JASN.

[61]  I. Lauder,et al.  Treatment of hyperlipidaemia in patients with non-insulin-dependent diabetes mellitus with progressive nephropathy. , 1997, Contributions to nephrology.

[62]  T Akizawa,et al.  Classification of dialysis membranes by performance. , 1995, Contributions to nephrology.

[63]  T. Balstad,et al.  Removal, generation and adsorption of beta-2-microglobulin during hemofiltration with five different membranes. , 1988, Blood purification.

[64]  M. Favero,et al.  Microbial contamination of renal dialysis systems and associated health risks. , 1974, Transactions - American Society for Artificial Internal Organs.

[65]  E Lusvarghi,et al.  Improved biocompatibility by modified cellulosic membranes: the case of hemophan. , 2008, Artificial organs.

[66]  J. Schifferli,et al.  Adsorption of complement factor D by polyacrylonitrile dialysis membranes. , 1993, Kidney international.

[67]  R. Cronin,et al.  Heterogeneity in gentamicin clearance between high-efficiency hemodialyzers. , 1994, American journal of kidney diseases : the official journal of the National Kidney Foundation.

[68]  W. Clark,et al.  Dialyzer-dependent changes in solute and water permeability with bleach reprocessing. , 1999, American journal of kidney diseases : the official journal of the National Kidney Foundation.